Results 51 to 60 of about 10,983 (153)

Research priorities for advanced HIV disease in Latin America and the Caribbean region: a modified Delphi study

Journal of the International AIDS Society, Volume 29, Issue 1, January 2026.
Abstract Introduction Advanced HIV disease (AHD) remains a leading cause of mortality in Latin America and the Caribbean (LAC), driven by late diagnosis, treatment gaps and structural barriers, particularly among key populations and children. Persistent disparities in healthcare access, stigma, and limited health system capacity highlight the need for ...
Evelina Chapman, Omar Sued, Jorge O. Maia Barreto, Claudia P. Cortes, Brenda Crabtree Ramírez, José E. Vidal, Antonio Camiro‐Zúñiga, Freddy Perez   +7 more
wiley   +1 more source

Cryptococcus gattii infection in an immunocompetent host in Greece

Medical Mycology Case Reports, 2020
We report a case of a 31-year-old otherwise healthy female with pulmonary cryptococcoma along with cryptococcal meningitis due to Cryptococcus gattii molecular type VGI, in Greece.
Marina Andreou, Massimo Cogliati, Fevronia Kolonitsiou, Charalampos Stroumpos, Vasiliki Stamouli, Panagiota Ravazoula, Dimitrios Siagris, Helen Papadogeorgaki, Myrto Christofidou, Alexandra Lekkou   +9 more
doaj   +1 more source

A cluster randomized trial of Visitect CD4 Advanced Disease platform among outpatients with advanced HIV disease in Uganda

Journal of the International AIDS Society, Volume 29, Issue 1, January 2026.
Abstract Introduction Despite significant progress in HIV care globally, a persistent 30–40% of people present with advanced HIV disease with ≤200 CD4 cells/µl. The Visitect CD4 Advanced Disease platform is a point‐of‐care CD4 test being implemented in resource‐limited settings.
Elizabeth Nalintya, Elizabeth L. Schwartz, Patricia Nerima, Ann Fieberg, Sarah M. Najjuka, Ruth E. Ajilong, Tessa Adzemovic, Olive Namakula, Atukunda Mucunguzi, Kiiza Kandole Tadeo, Mark Oilor, Preethiya Sekar, Alice Lehman, Bruce Larson, Biyue Dai, David B. Meya, David R. Boulware, Radha Rajasingham, the ENCORE team   +18 more
wiley   +1 more source

Imidazolium‐Based Ionic Liquids as Antifungal and Antibiofilm Agents Against Candida tropicalis

ChemistrySelect, Volume 11, Issue 4, 28 January 2026.
Candida sp. biofilms, particularly those formed on catheters, represent a major clinical challenge. This study evaluates ionic liquids using an experimental biofilm model, demonstrating significant antifungal activity and biofilm disruption, supporting their potential application as alternative strategies for device‐associated infection control ...
Giovanna de Jesus Agostinetto, Paula Reginatto, Lavínia da Veiga Pereira, Clarissa Piccinin Frizzo, Alexandre Meneghello Fuentefria   +4 more
wiley   +1 more source

Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025

HIV Medicine, Volume 27, Issue 1, Page 18-32, January 2026.
Abstract Background The European AIDS Clinical Society (EACS) guidelines were revised for the 21st time in 2025, with updates covering all aspects of HIV care. Key Points of the Guidelines Update The structure of the guidelines has been reorganized into two parts: Part I focuses on the management and prevention of HIV and related infections, and Part ...
Juan Ambrosioni, Laura I. Levi, Jasmini Alagaratnam, Abiu Sempere, Andrea Mastrangelo, Paolo Paioni, Cristina Mussini, Catia Marzolini, Susanne Dam Nielsen, Charles Béguelin, Steven Welch, Anna Koval, Luis Mendao, Alasdair Bamford, Alexandra Calmy, Giovanni Guaraldi, Cristiana Oprea, Esteban Martínez, Jürgen K. Rockstroh, The EACS Governing Board   +19 more
wiley   +1 more source

Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts

Mycoses, Volume 69, Issue 1, January 2026.
ABSTRACT The Mycoses Study Group Education and Research Consortium (MSGERC)—a group comprising clinicians, researchers, patients, and industry partners—meets every 2 years to review the most significant challenges facing the clinical mycology community and plan research, education, and advocacy strategies to prevent fungal infections and improve ...
A. Apostolopoulou, A. G. Stewart, H. Yoon, J. M. Steinbrink, D. Z. P. Friedman, L. Ostrosky‐Zeichner, I. S. Schwartz, on behalf of the Mycoses Study Group Education and Research Consortium (MSGERC)   +7 more
wiley   +1 more source

Non-acquired immunodeficiency syndrome-related cryptococcal meningitis with recurrent acute stroke: A case report

Journal of International Medical Research
Cryptococcal meningitis has been reported to be primarily associated with human immunodeficiency virus infection. Herein, we report the case of a male patient in China with recurrent acute stroke as the first clinical manifestation, followed by several ...
Bijun Ye, Jian Wu, Yinhong Qiu, Weiqiang Fan, Jiating Xu, Yiping Tang   +5 more
doaj   +1 more source

Stewardship of Molecular Diagnostics in Transplant Viral Infections

Transplant Infectious Disease, Volume 28, Issue 1, January/February 2026.
ABSTRACT The transplant environment requires special considerations when testing for viral infections as immunosuppression results in atypical infection profiles. Microbes otherwise considered commensals or causing mild disease can lead to severe infections in transplant environments. Therefore, guidelines tend to recommend broader microbial testing in
Scott Sugden, David Reynoso, Reema Mathew, Michael Loeffelholz   +3 more
wiley   +1 more source

Shunting in cryptococcal meningitis [PDF]

Journal of Neurosurgery, 2016
OBJECT Patients with cryptococcal meningitis often develop symptomatic intracranial hypertension. The need for permanent CSF diversion in these cases remains unclear. METHODS Cases of cryptococcal meningitis over a 5-year period were reviewed from a single, large teaching hospital.
Jacob, Cherian, Robert L, Atmar, Shankar P, Gopinath   +2 more
openaire   +2 more sources

Effects of Two Anti‐HIV‐1 Regimens on Creatinine and Blood Lipids in Elderly People Living With HIV‐1

AIDS Research and Treatment, Volume 2026, Issue 1, 2026.
Background Elderly people living with HIV‐1 (PLWH) are more prone to HIV‐related complications. Methods We investigated the creatinine and blood lipids of 153 PLWHs receiving an ANV regimen and 315 PLWHs receiving an EFV regimen. Results The results showed that the abnormal rates of creatinine were very low in both groups, and ANV had a lower ...
Peipei Luo, Juan Jin, Jinling Yin, Dingsheng Kong, Haohua Hou, Guoxiang Yang, Huanhuan Ba, Jiajia Li, Kwame Yeboah   +8 more
wiley   +1 more source